why choose us

First received: August 5, 2022

Clinical Trial: External Comparison of Ibalizumab in Trials vs. Other Regimens in OPERA

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: HIV-1-infection

Study Type: Observational


Official Title: External Comparison of Effectiveness of Ibalizumab in Clinical Trials vs. Other HTE Regimens in OPERA

Brief Summary: Among heavily treatment experienced people living with HIV, the virologic effectiveness of ibalizumab + optimized background regimen from two clinical trials will be compared to non-ibalizumab-containing regimens in routine clinical care in the OPERA cohort.

Read more